ProfileGDS4132 / 225392_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 88% 81% 82% 84% 85% 86% 75% 90% 84% 83% 89% 87% 86% 88% 83% 86% 86% 84% 82% 85% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101372.63588
GSM201543Muscle PCOS pioglitazone 121268.99281
GSM201544Muscle PCOS pioglitazone 161309.55682
GSM201545Muscle PCOS pioglitazone 201345.50584
GSM201829Muscle PCOS pioglitazone 231334.7285
GSM201830Muscle PCOS pioglitazon 251343.74386
GSM201831Muscle PCOS pioglitazone 271247.28275
GSM201832Muscle PCOS pioglitazone 31410.31190
GSM201833Muscle PCOS pioglitazone 41315.53384
GSM201834Muscle PCOS pioglitazone 81319.02983
GSM201835Muscle PCOS after pioglitazone 102437.09189
GSM201836Muscle PCOS after pioglitazone 122365.85687
GSM201837Muscle PCOS after pioglitazone 162337.74486
GSM201838Muscle PCOS after pioglitazone 202425.11188
GSM201839Muscle PCOS after pioglitazone 232316.46483
GSM201840Muscle PCOS after pioglitazone 252370.19586
GSM201841Muscle PCOS after pioglitazone 272340.3686
GSM201842Muscle PCOS after pioglitazone 32293.26684
GSM201843Muscle PCOS after pioglitazone 42292.73382
GSM201844Muscle PCOS after pioglitazone 82353.02585